Clevudine Therapy for 24 Weeks Further Reduced Serum Hepatitis B Virus DNA Levels and Increased ALT Normalization Rates without Emergence of Viral Breakthrough than 12 Weeks of Clevudine Therapy

Publisher： Karger

E-ISSN： 1423-0100|50|4|296-302

ISSN： 0300-5526

Source： Intervirology, Vol.50, Iss.4, 2007-07, pp. : 296-302

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The assessment of serum hepatitis C virus RNA 12 weeks after the end of treatment using TaqMan polymerase chain reaction is less relevant than after 24 weeks for predicting sustained virological response

By  

HEPATOLOGY, Vol. 54, Iss. 4, 2011-10 ,pp. : 1482-1482

John Wiley & Sons Inc

Access to resources Recommend Favorite

Viral Breakthrough during Lamivudine Therapy for Chronic Hepatitis B

By  

Intervirology, Vol. 46, Iss. 6, 2003-12 ,pp. : 344-349

Karger

Access to resources Recommend Favorite

Clevudine Demonstrates Potent Antiviral Activity in Naïve Chronic Hepatitis B Patients

By  

Intervirology, Vol. 53, Iss. 2, 2009-12 ,pp. : 83-86

Karger

Access to resources Recommend Favorite

Infection by an unenveloped DNA virus associated with non‐A to ‐G hepatitis in Japanese blood donors with or without elevated ALT levels

By  

TRANSFUSION, Vol. 39, Iss. 5, 1999-05 ,pp. : 522-526

John Wiley & Sons Inc

Access to resources Recommend Favorite

Eicosapentaenoic Acid Could Permit Maintenance of the Original Ribavirin Dose in Chronic Hepatitis C Virus Patients during the First 12 Weeks of Combination Therapy with Pegylated Interferon-α and Ribavirin

By  

Intervirology, Vol. 50, Iss. 6, 2008-02 ,pp. : 439-446

Karger

Access to resources Recommend Favorite